News

Initial public offerings scheduled to debut next week

NEW YORK, N.Y. – The following is a list of initial public offerings planned for the coming week. Sources include Renaissance Capital, Greenwich, CT (www.renaissancecapital.com) and SEC filings.

Week of May 27

Epizyme Inc. – Cambridge, Mass., 4.3 million shares, priced at $13 to $15, managed by Citigroup, Cowen & Co., and Leerink Swann. Proposed Nasdaq symbol EPZM. Business: Biotech developing therapeutics for patients with genetically defined cancers.

Kamada Ltd. – Ness Ziona, Israel, 5.6 million ordinary shares, priced at $11 each managed by Morgan Stanley and Jefferies. Proposed Nasdaq symbol KMDA. Business: Provides plasma-derived protein therapeutics mostly in Israel and the U.S. Stock trades on the Tel Aviv exchange.